MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

DownloadDownload image
Net loss-$22,386K (-72.49%↓ Y/Y)Operating loss-$15,298K (-4.10%↓ Y/Y)Total other income(expense)-$7,088K (-512.81%↓ Y/Y)Revenue$5,213K (-10.49%↓ Y/Y)Interest income$116K (-57.51%↓ Y/Y)Total operatingexpenses$20,511K (-0.04%↓ Y/Y)Financing expense$3,061K (-13.65%↓ Y/Y)Change in fair value ofderivative instruments$2,631K Warrant issuance costs$964K (98.35%↑ Y/Y)Interest expense$548K (206.15%↑ Y/Y)General andadministrative$12,132K (22.06%↑ Y/Y)Research and development$8,379K (-20.80%↓ Y/Y)
Income Statement
source: myfinsight.com

PLUS THERAPEUTICS, INC. (PSTV)

PLUS THERAPEUTICS, INC. (PSTV)